Amarin (AMRN) Stock Price
$0.565 4.7%
to add to portfolio
AI Score
-
Alternative
1 -
Fundamental
0 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Amarin, AI stock picks, stock alerts and much more.
AMRN AI Stock Analysis
AI stock analysis for AMRN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Amarin (AMRN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Amarin (AMRN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Amarin (AMRN), currently trading at $0.565, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AMRN
-
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates.
-
Symbol
AMRN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
232.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.91 4.7% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.15 1.8% |
4 |
 |
Moderna MRNA |
$43.59 3% |
4 |
 |
Anavex Life Sciences AVXL |
$9.73 1.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.32 0% |
7 |
News
AMRN Alternative Data
Web Traffic
Amarin receives an estimated 1757 monthly visitors to amarincorp.com.
-
Web Traffic
1757
-
Change from Previous Month
62.3%
-
3 Month Change
75.9%
-
YoY Change
75.9%
News Mentions
Amarin was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Amarin has an estimated 3 open job postings, which is down -40% over the last month.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
40%
-
3 Month Change
25%
-
YoY Change
25%
LinkedIn Employees
According to LinkedIn, Amarin has 464 employees, up by 4.7% over the last month.
-
LinkedIn Employees
464
-
Daily Change
0%
-
1 Month Change
4.7%
-
3 Month Change
3.1%
-
YoY Change
3.1%
Twitter Followers
Amarin has 2,210 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
2210
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Business Outlook
-
Business Outlook
26
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Facebook Engagement
Amarin has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
AMRN Financials
AMRN Key Metrics
-
Total Revenue
$41.9M
-
Net Income
-$25.1M
-
Earnings per Share
-$0.0611
-
Free cash flow
-$2.4M
-
EBITDA
-$25.2M
-
EBITDA Ratio
-0.601357
-
Total Assets
$750.6M
AMRN 2-year Revenue & Income
AMRN 2-year Free Cash Flow
AMRN Technicals
AMRN SMA
AMRN RSI
FAQ
What's the current price of Amarin (AMRN) Stock?
The price of an Amarin (AMRN) share is $0.565.
What's the market cap of Amarin?
The current market cap of Amarin is 232.2M.
Should I buy or sell AMRN?
Amarin exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Amarin a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Amarin stock. There are several bearish signals and market challenges that could negatively impact Amarin's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Amarin (AMRN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Amarin stock right now, as the outlook appears bearish.
What are some stocks similar to Amarin (AMRN) that investors often compare it to?
Amarin (AMRN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Amarin's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Amarin's stock price to be around $0.481 in 2026. Starting from the current price of $0.565, this represents a 14.9% change in price, indicating a bearish outlook for the stock.
How to buy Amarin (AMRN) Stock?
Amarin stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Amarin shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.